Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06069102Phase 4Completed
Phase 4, randomised, open-label trial in hypertensive disorder of pregnancy (HDP) (2 arms). Primary endpoint: Percent of Participants Eligible, Enrolled and Retained at 6 months. Started Nov 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06069102.